MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$8,688K Prepaid expenses andother current assets$1,508K Other receivables$472K Operating leaseright-of-use asset$33,911K Property and equipment,net$12,194K Total current assets$10,668K In-process research anddevelopment$10,256K Restricted cash$5,390K Goodwill$3,490K Other assets$973K Total assets$76,882K Accumulated deficit-$501,534K Total liabilities andstockholders' deficit$76,882K Total stockholders'deficit-$218,596K Additional paid-in capital$282,574K Common stock, 0.01 parvalue 217,000,000...$364K Total liabilities$295,478K Convertible loan,non-current$153,860K Term debt,non-current$103,061K Operating leaseliabilities, net of current...$26,533K Total currentliabilities$8,947K Deferred tax liability$3,077K Current portion ofoperating lease...$4,564K Accrued compensation$2,191K Accounts payable andaccrued liabilities$1,705K Other currentliabilities$487K
Balance Sheet
source: myfinsight.com

Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals, Inc. (ARMP)